US4602035A
(en)
*
|
1983-12-07 |
1986-07-22 |
Hoechst-Roussel Pharmaceuticals Inc. |
Antidepressant (3-aryl-2,3-dihydrobenzofuran-3-yl)alkylamines
|
GB8419963D0
(en)
*
|
1984-08-06 |
1984-09-12 |
Lundbeck & Co As H |
Intermediate compound and method
|
GB8814057D0
(en)
*
|
1988-06-14 |
1988-07-20 |
Lundbeck & Co As H |
New enantiomers & their isolation
|
EP0759299B1
(en)
*
|
1995-08-16 |
2000-04-26 |
Eli Lilly And Company |
Potentiation of serotonin response
|
JP3526581B2
(ja)
|
1997-07-08 |
2004-05-17 |
ハー・ルンドベック・アクティーゼルスカブ |
シタロプラムの製造方法
|
UA62985C2
(en)
*
|
1997-11-10 |
2004-01-15 |
Lunnbeck As H |
A method for the preparation of citalopram
|
DE69714480T2
(de)
*
|
1997-11-11 |
2003-03-06 |
Lundbeck & Co As H |
Verfahren zur Herstellung von Citalopram
|
WO2000023431A1
(en)
|
1998-10-20 |
2000-04-27 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
KR20010081071A
(ko)
|
1998-12-08 |
2001-08-25 |
피터슨 존 메이달 |
벤조푸란 유도체, 그것들의 제조 및 사용
|
AR021509A1
(es)
*
|
1998-12-08 |
2002-07-24 |
Lundbeck & Co As H |
Derivados de benzofurano, su preparacion y uso
|
CZ300408B6
(cs)
|
1998-12-23 |
2009-05-13 |
H. Lundbeck A/S |
Zpusob výroby 5-kyanoftalidu
|
AR022329A1
(es)
|
1999-01-29 |
2002-09-04 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-cianoftalida
|
PL198024B1
(pl)
*
|
1999-04-14 |
2008-05-30 |
Lundbeck & Co As H |
Sposób wytwarzania citalopramu, związki pośrednie i ich zastosowanie do wytwarzania citalopramu
|
ITMI991579A1
(it)
*
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
ITMI991581A1
(it)
*
|
1999-06-25 |
2001-01-15 |
Lundbeck & Co As H |
Metodo per la preparazione di citalopram
|
ITMI991486A1
(it)
*
|
1999-07-06 |
2001-01-06 |
Vis Farmaceutici S P A |
Processo per la sintesi di citalopram
|
AR021155A1
(es)
*
|
1999-07-08 |
2002-06-12 |
Lundbeck & Co As H |
Tratamiento de desordenes neuroticos
|
TR200101874T1
(tr)
|
1999-10-25 |
2002-02-21 |
H. Lundbeck A/S |
Sitalopram hazırlanması için yöntem
|
EA002801B1
(ru)
|
1999-10-25 |
2002-10-31 |
Х.Лундбекк А/С |
Способ получения циталопрама
|
US6310222B1
(en)
|
1999-11-01 |
2001-10-30 |
Sumika Fine Chemicals Co., Ltd. |
Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate
|
AR026063A1
(es)
|
1999-11-01 |
2002-12-26 |
Lundbeck & Co As H |
Metodo para la preparacion de 5-carboxiftalida.
|
ATE261953T1
(de)
*
|
1999-12-28 |
2004-04-15 |
Lundbeck & Co As H |
Verfahren zur herstellung von citalopram
|
TR200201688T2
(tr)
*
|
1999-12-30 |
2002-11-21 |
H. Lundbeck A/S |
Sitalopram hazırlama yöntemi.
|
EA005134B1
(ru)
*
|
2000-01-14 |
2004-12-30 |
Х.Лундбекк А/С |
Способ получения 5-цианофталида
|
US6433196B1
(en)
*
|
2000-02-17 |
2002-08-13 |
Sumika Fine Chemicals Co., Ltd. |
Production method of citalopram, intermediate therefor and production method of the intermediate
|
IES20010143A2
(en)
*
|
2000-02-24 |
2001-07-25 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
NL1017415C1
(nl)
*
|
2000-02-24 |
2001-05-18 |
Lundbeck & Co As H |
Werkwijze voor de bereiding van Citalopram.
|
IES20010157A2
(en)
|
2000-03-03 |
2002-03-06 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
GB0005477D0
(en)
|
2000-03-07 |
2000-04-26 |
Resolution Chemicals Limited |
Process for the preparation of citalopram
|
TR200202166T2
(tr)
|
2000-03-13 |
2002-12-23 |
H. Lndbeck A/S |
Sitalopramın preparasyon metodu
|
EA200200968A1
(ru)
*
|
2000-03-13 |
2003-02-27 |
Х.Лундбекк А/С |
Поэтапное алкилирование 5-замещенных 1-(4-фторфенил)-1,3-дигидроизобензофуранов
|
IES20010206A2
(en)
|
2000-03-13 |
2002-03-06 |
Lundbeck & Co As H |
Method for the preparation of citalopram
|
GB2357762B
(en)
*
|
2000-03-13 |
2002-01-30 |
Lundbeck & Co As H |
Crystalline base of citalopram
|
CA2402557A1
(en)
|
2000-03-14 |
2001-09-20 |
Hans Petersen |
Method for the preparation of citalopram
|
CA2402869A1
(en)
*
|
2000-03-16 |
2001-09-20 |
Hans Petersen |
Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans
|
EP1284729A4
(en)
*
|
2000-04-13 |
2007-12-19 |
Mayo Foundation |
REDUCTION AGENTS OF A (BETA) 42
|
US6977306B2
(en)
*
|
2000-05-02 |
2005-12-20 |
Sumitomo Chemical Company, Limited |
Citalopram hydrobromide crystal and method for crystallization thereof
|
AR032455A1
(es)
*
|
2000-05-12 |
2003-11-12 |
Lundbeck & Co As H |
Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva
|
KR100821912B1
(ko)
*
|
2000-05-12 |
2008-04-16 |
하. 룬트벡 아크티에 셀스카브 |
시탈로프람의 제조 방법
|
EA200200332A1
(ru)
*
|
2000-07-06 |
2002-06-27 |
Х.Лундбекк А/С |
Способ получения циталопрама
|
BR0113011A
(pt)
*
|
2000-07-21 |
2003-07-01 |
Lundbeck & Co As H |
Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento
|
IES20010693A2
(en)
*
|
2000-08-10 |
2002-07-10 |
Lundbeck & Co As H |
Pharmaceutical composition containing citalopram
|
CA2354880C
(en)
*
|
2000-08-18 |
2003-06-03 |
H. Lundbeck A/S |
Method for the preparation of citalopram
|
US20030109577A1
(en)
*
|
2000-10-27 |
2003-06-12 |
Ken Liljegren |
Pharmaceutical composition containing citalopram
|
US20030232881A1
(en)
*
|
2000-10-27 |
2003-12-18 |
H. Lundbeck A/S |
Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
|
IT1319686B1
(it)
*
|
2000-12-12 |
2003-10-23 |
C D Farmasint S R L |
Procedimento di preparazione di citalopram.
|
KR100439329B1
(ko)
*
|
2000-12-22 |
2004-07-07 |
하. 룬트벡 아크티에 셀스카브 |
순수한 시탈로프람의 제조방법
|
DE10164725B4
(de)
*
|
2000-12-28 |
2004-08-26 |
H. Lundbeck A/S |
Verfahren zur Herstellung von gereinigtem Citalopram
|
AU3920201A
(en)
*
|
2000-12-28 |
2001-07-09 |
H. Lundbeck A/S |
Process for the preparation of pure citalopram
|
DE10112828C1
(de)
*
|
2000-12-28 |
2002-11-21 |
Lundbeck & Co As H |
Verfahren zur Herstellung von Citalopram
|
AU2001100195B4
(en)
*
|
2001-01-05 |
2001-12-20 |
H Lundbeck As |
Pharmaceutical composition containing citalopram.
|
CA2435925A1
(en)
|
2001-01-30 |
2002-08-08 |
Orion Corporation Fermion |
Process for the preparation of 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
|
WO2002066453A1
(en)
*
|
2001-02-22 |
2002-08-29 |
Natco Pharma Limited |
Process for the preparation of citalopram
|
GB0105627D0
(en)
*
|
2001-03-07 |
2001-04-25 |
Cipla Ltd |
Preparation of phthalanes
|
CA2439856A1
(en)
*
|
2001-03-09 |
2002-09-19 |
Swargam Sathyanarayana |
Process for the preparation of citalopram
|
PL367480A1
(en)
*
|
2001-05-01 |
2005-02-21 |
H.Lundbeck A/S |
The use of enantiomeric pure escitalopram
|
BG65271B1
(bg)
*
|
2001-06-18 |
2007-11-30 |
H. Lundbeck A/S |
Метод за получаване на циталопрам
|
AR034759A1
(es)
*
|
2001-07-13 |
2004-03-17 |
Lundbeck & Co As H |
Metodo para la preparacion de escitalopram
|
IN192057B
(nl)
*
|
2001-07-19 |
2004-02-14 |
Ranbaxy Lab Ltd |
|
CN1660074A
(zh)
*
|
2001-07-31 |
2005-08-31 |
H·隆德贝克有限公司 |
含有依他普仑的晶体组合物
|
EP1288211A1
(en)
*
|
2001-08-28 |
2003-03-05 |
Sekhsaria Chemicals Ltd. |
Improved process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
US6967259B2
(en)
*
|
2001-09-24 |
2005-11-22 |
Pharmachem Technologies Limited |
Process for the preparation of Citalopram intermediate
|
EP1434763B1
(en)
*
|
2001-10-12 |
2018-01-17 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl vasopressin v1a antagonists
|
IN192863B
(nl)
*
|
2001-11-13 |
2004-05-22 |
Ranbaxy Lab Ltd |
|
IS7239A
(is)
*
|
2001-12-14 |
2004-04-29 |
H. Lundbeck A/S |
Aðferð til framleiðslu á essítalóprami
|
US7148364B2
(en)
*
|
2002-01-07 |
2006-12-12 |
Sun Pharmaceutical Industries |
Process for the preparation of 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile
|
GB2385848A
(en)
*
|
2002-02-27 |
2003-09-03 |
Cipla Ltd |
Citalopram salts
|
GB0204607D0
(en)
*
|
2002-02-27 |
2002-04-10 |
Matrix Lab Ltd |
Process
|
GB2387844B
(en)
*
|
2002-02-27 |
2005-05-11 |
Matrix Lab Ltd |
Separation of impurities from a crude mixture of citalopram
|
EP1346989A1
(en)
*
|
2002-03-21 |
2003-09-24 |
Jubilant Organosys Limited |
Improved process for the preparation of citalopram and its hydrobromide
|
CN100402489C
(zh)
*
|
2002-03-27 |
2008-07-16 |
坂东化学株式会社 |
新型1,3,5-三(芳氨基)苯类
|
CA2381341A1
(en)
*
|
2002-04-09 |
2003-10-09 |
Torcan Chemical Ltd. |
Process and intermediates for preparing escitalopram
|
FI20021421A0
(fi)
*
|
2002-07-30 |
2002-07-30 |
Orion Corp Fermion |
Valmistusmenetelmä
|
PE20040991A1
(es)
|
2002-08-12 |
2004-12-27 |
Lundbeck & Co As H |
Separacion de intermediarios para la preparacion de escitalopram
|
WO2004016602A1
(en)
*
|
2002-08-14 |
2004-02-26 |
Natco Pharma Limited |
Process for the preparation of high purity citalopram and its pharmaceutically acceptable salts
|
GB2385051B
(en)
*
|
2002-08-29 |
2003-12-24 |
Max India Ltd |
Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans
|
US6812355B2
(en)
|
2002-10-22 |
2004-11-02 |
Sekhsaria Chemicals Limited |
Process for the manufacture of citalopram hydrobromide from 5-bromophthalide
|
US20050137255A1
(en)
*
|
2002-12-23 |
2005-06-23 |
H. Lundbeck A/S |
Crystalline escitalopram hydrobromide and methods for preparing the same
|
CA2511142A1
(en)
*
|
2002-12-23 |
2004-07-08 |
H. Lundbeck A/S |
Escitalopram hydrobromide and a method for the preparation thereof
|
AU2003242990A1
(en)
*
|
2003-01-17 |
2004-08-13 |
Pulla Reddy Muddasani |
Processes for the preparation of escitalopram and its precursor
|
EP1603548A4
(en)
*
|
2003-02-05 |
2007-10-10 |
Myriad Genetics Inc |
COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
|
ITMI20030479A1
(it)
*
|
2003-03-13 |
2004-09-14 |
Adorkem Technology S P A |
Procedimento per la preparazione di un ciano-isobenzofurano.
|
US7019153B2
(en)
*
|
2003-06-10 |
2006-03-28 |
Sun Pharmaceutical Industries Limited |
Process for hydrogenolysis of [1-(3-dimethylamino)propyl)]-1-(4-fluorophenyl)-1,3-dihydro-5-halo-isobenzofuran acetamido-3-substituted-3-cephem-4-carboxylic acid
|
AU2004311577A1
(en)
*
|
2003-07-11 |
2005-07-21 |
Myriad Genetics, Inc. |
Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
|
GB0317475D0
(en)
*
|
2003-07-25 |
2003-08-27 |
Meditab Specialities Pvt Ltd |
Product
|
ITFI20030202A1
(it)
*
|
2003-07-28 |
2005-01-29 |
Synteco Spa |
Processo per la preparazione di derivati del
|
KR101151653B1
(ko)
*
|
2003-09-17 |
2012-06-28 |
얀센 파마슈티카 엔.브이. |
융합된 헤테로사이클릭 화합물
|
WO2005042473A1
(en)
*
|
2003-10-28 |
2005-05-12 |
Wockhardt Limited |
Improved process for the manufacture of citalopram hydrobromide
|
PT1506963E
(pt)
*
|
2003-10-28 |
2005-08-31 |
Adorkem Technology Spa |
Processo para a preparacao de citalopram
|
US20050143350A1
(en)
*
|
2003-11-19 |
2005-06-30 |
Seed John C. |
Combination drug therapy to treat obesity
|
EP2272514A1
(en)
*
|
2003-12-02 |
2011-01-12 |
PharmaNeuroBoost N.V. |
Use of low dose pipamperone and a second active compound in the treatment of neurodegenerative diseases
|
EP2343073A3
(en)
|
2003-12-11 |
2011-10-12 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
CN100569765C
(zh)
*
|
2003-12-19 |
2009-12-16 |
杭州民生药业集团有限公司 |
西酞普兰中间体晶体碱
|
TWI339651B
(en)
*
|
2004-02-12 |
2011-04-01 |
Lundbeck & Co As H |
Method for the separation of intermediates which may be used for the preparation of escitalopram
|
EP1723133A1
(en)
*
|
2004-02-16 |
2006-11-22 |
Jubilant Organosys Limited |
One pot synthesis of citalopram from 5-cyanophthalide
|
US20050196453A1
(en)
*
|
2004-03-05 |
2005-09-08 |
H. Lundbeck A/S |
Crystalline composition containing escitalopram
|
ITMI20040717A1
(it)
*
|
2004-04-09 |
2004-07-09 |
Adorkem Technology Spa |
Procedimento chemo-enzimatico per la preparazione dell'escitalopram
|
WO2006001877A2
(en)
*
|
2004-04-13 |
2006-01-05 |
Myriad Genetics, Inc. |
Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
|
US20050233010A1
(en)
*
|
2004-04-19 |
2005-10-20 |
Satow Philip M |
Lithium combinations, and uses related thereto
|
EP1745180A1
(en)
*
|
2004-04-29 |
2007-01-24 |
Keystone Retaining Wall Systems, Inc. |
Veneers for walls, retaining walls and the like
|
WO2006020852A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
WO2006020850A2
(en)
*
|
2004-08-11 |
2006-02-23 |
Myriad Genetics, Inc. |
Pharmaceutical composition and method for treating neurodegenerative disorders
|
BRPI0514303A
(pt)
*
|
2004-08-11 |
2008-06-10 |
Myriad Genetics Inc |
composição farmacêutica e método para tratar distúrbios neurodegenerativos
|
EP1797060A2
(en)
|
2004-08-23 |
2007-06-20 |
Sun Pharmaceutical Industries Limited |
"process for preparation of citalopram and enantiomers"
|
US7989645B2
(en)
*
|
2004-08-23 |
2011-08-02 |
Sun Pharma Global Fze |
Process for preparation of citalopram and enantiomers
|
US9597314B2
(en)
|
2005-03-22 |
2017-03-21 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamylalkanoic acids for treating premenstrual disorders
|
WO2006103550A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Ranbaxy Laboratories Limited |
Processes for the preparation of citalopram and its intermediate 5-aminophthalide
|
EP1871358A1
(en)
|
2005-04-22 |
2008-01-02 |
Wyeth |
Benzofuranyl alkanamine derivatives and uses thereof as 5-ht2c agonists
|
GT200600164A
(es)
|
2005-04-22 |
2007-03-14 |
|
Derivados de dihidrobenzofuranos y usos de los mismos
|
GT200600165A
(es)
*
|
2005-04-22 |
2007-03-14 |
|
Derivados dihidrobenzofuranos y usos de los mismos
|
US20060252825A1
(en)
*
|
2005-04-22 |
2006-11-09 |
Wyeth |
Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
|
US7834201B2
(en)
|
2005-06-22 |
2010-11-16 |
H. Lundbeck A/S |
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
|
TWI358407B
(en)
|
2005-06-22 |
2012-02-21 |
Lundbeck & Co As H |
Crystalline base of escitalopram and orodispersibl
|
WO2007008758A2
(en)
*
|
2005-07-08 |
2007-01-18 |
Braincells, Inc. |
Methods for identifying agents and conditions that modulate neurogenesis
|
US20070015832A1
(en)
*
|
2005-07-14 |
2007-01-18 |
Myriad Genetics, Incorporated |
Methods of treating overactive bladder and urinary incontinence
|
KR101523776B1
(ko)
|
2005-07-19 |
2015-05-28 |
아제반 파마슈티칼스, 인코퍼레이티드 |
베타-락타민 페닐알라닌, 시스테인 그리고 세린 바소프레신길항물질
|
JP2009502807A
(ja)
*
|
2005-07-22 |
2009-01-29 |
ミリアド ジェネティクス, インコーポレイテッド |
薬剤含有率の高い製剤および投与量形態
|
US7598255B2
(en)
*
|
2005-08-04 |
2009-10-06 |
Janssen Pharmaceutica Nv |
Pyrimidine compounds as serotonin receptor modulators
|
JP2009512711A
(ja)
|
2005-10-21 |
2009-03-26 |
ブレインセルス,インコーポレイティド |
Pde阻害による神経新生の調節
|
CA2625210A1
(en)
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
JP2009515840A
(ja)
*
|
2005-11-14 |
2009-04-16 |
ハー・ルンドベック・アクチエゼルスカベット |
エスシタロプラムの製造方法
|
GB0601286D0
(en)
|
2006-01-23 |
2006-03-01 |
Sandoz Ag |
Asymmetric synthesis
|
FR2912057B1
(fr)
*
|
2007-02-07 |
2009-04-17 |
Sanofi Aventis Sa |
Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
|
AU2007223036A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
US20100216734A1
(en)
*
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
CA2644662A1
(en)
*
|
2006-03-24 |
2007-10-04 |
Wyeth |
New therapeutic combinations for the treatment of depression
|
US7858611B2
(en)
*
|
2006-05-09 |
2010-12-28 |
Braincells Inc. |
Neurogenesis by modulating angiotensin
|
AU2007249435A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
WO2007134136A2
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
US20100009983A1
(en)
*
|
2006-05-09 |
2010-01-14 |
Braincells, Inc. |
5 ht receptor mediated neurogenesis
|
US20080033045A1
(en)
*
|
2006-07-07 |
2008-02-07 |
Myriad Genetics, Incorporated |
Treatment of psychiatric disorders
|
WO2008059514A2
(en)
*
|
2006-07-31 |
2008-05-22 |
Cadila Healthcare Limited |
Process for preparing escitalopram
|
TW200817003A
(en)
*
|
2006-07-31 |
2008-04-16 |
Sanofi Aventis |
Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
|
KR20090064418A
(ko)
*
|
2006-09-08 |
2009-06-18 |
브레인셀즈 인코퍼레이션 |
4-아실아미노피리딘 유도체 포함 조합물
|
WO2008034032A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Azevan Pharmaceuticals, Inc. |
Beta-lactam cannabinoid receptor modulators
|
WO2008036678A2
(en)
*
|
2006-09-19 |
2008-03-27 |
Braincells, Inc. |
Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
JP4927497B2
(ja)
*
|
2006-10-25 |
2012-05-09 |
株式会社シスコ |
無湿乾燥用ホッパー装置
|
CN100457747C
(zh)
*
|
2006-11-21 |
2009-02-04 |
浙江大学 |
抗抑郁药西酞普兰关键中间体5-氰基苯酞的制备工艺
|
WO2008083204A2
(en)
*
|
2006-12-28 |
2008-07-10 |
Braincells, Inc. |
Modulation of neurogenesis by melatoninergic ligands
|
EP2125017A2
(en)
*
|
2007-01-11 |
2009-12-02 |
Braincells, Inc. |
Modulation of neurogenesis with use of modafinil
|
ATE534639T1
(de)
*
|
2007-04-23 |
2011-12-15 |
Synthon Bv |
Verfahren zur lösung von citalopram
|
NZ580738A
(en)
*
|
2007-05-18 |
2012-02-24 |
Cipla Ltd |
Process for the preparation of escitalopram
|
US20080312318A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Protia, Llc |
Deuterium-enriched escitalopram
|
EP2017271A1
(en)
|
2007-07-06 |
2009-01-21 |
Aurobindo Pharma Limited |
Process for the preparation of escitalopram
|
US8022232B2
(en)
*
|
2007-09-11 |
2011-09-20 |
H. Lundbeck A/S |
Method for manufacture of escitalopram
|
KR101103118B1
(ko)
*
|
2007-11-02 |
2012-01-04 |
동아제약주식회사 |
신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물
|
EP2288345B1
(en)
|
2008-04-18 |
2015-06-10 |
University College Dublin National University Of Ireland, Dublin |
Psycho-pharmaceuticals
|
EP2116231A1
(en)
|
2008-05-07 |
2009-11-11 |
Hexal Ag |
Granulate comprising escitalopram oxalate
|
US20100087664A1
(en)
*
|
2008-10-07 |
2010-04-08 |
Ravindra Vedantham |
Preparation of citalopram and salts thereof
|
GR20080100696A
(el)
|
2008-10-23 |
2010-05-13 |
Genepharm �.�. |
Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
JO3267B1
(ar)
|
2009-10-23 |
2018-09-16 |
Janssen Pharmaceutica Nv |
بيرولات [3، 4-سي] اوكتاهيدروبيرولو ثنائية الاستبدال كمعدلات لمستقبل اوريكسين
|
CA2804001C
(en)
|
2010-07-01 |
2021-02-09 |
Azevan Pharmaceuticals, Inc. |
Methods for treating post traumatic stress disorder
|
WO2013100870A1
(en)
|
2011-12-02 |
2013-07-04 |
Mahmut Bilgic |
New antipsychotic compositions
|
WO2013081567A1
(en)
|
2011-12-02 |
2013-06-06 |
Mahmut Bilgic |
Effervescent antipsychotic formulations
|
WO2013110313A1
(en)
*
|
2012-01-23 |
2013-08-01 |
H. Lundbeck A/S |
Selective allosteric modulators of the serotonin transporter
|
BR112016022575A2
(pt)
|
2014-03-28 |
2017-08-15 |
Azevan Pharmaceuticals Inc |
Composições e métodos para o tratamento de doenças neurodegenerativas
|
ES2913469T3
(es)
|
2016-03-10 |
2022-06-02 |
Janssen Pharmaceutica Nv |
Métodos para tratar la depresión usando antagonistas del receptor de orexina-2
|
CN111295373A
(zh)
|
2017-09-15 |
2020-06-16 |
阿泽凡药物公司 |
用于治疗脑损伤的组合物和方法
|
JP2022540706A
(ja)
|
2019-07-19 |
2022-09-16 |
バイオエクセル セラピューティクス,インコーポレイテッド |
鎮静作用のないデクスメデトミジン治療レジメン
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|